As an investment holding company, Prenetics Global Limited specializes in providing diagnostic and genetic testing services. Its comprehensive product line features CircleDNA, ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $-0.77 · Revenue $63.08M · 3 analysts
Est. EPS $-0.70 · Revenue $77.07M · 3 analysts
Est. EPS $-3.46 · Revenue $223.26M · 2 analysts
Est. EPS $-0.53 · Revenue $83.07M · 1 analysts
EPS $-0.52 · Revenue $46.49M
EPS $-1.36 · Revenue $35.95M
EPS $-2.68 · Revenue $92.39M
EPS $-0.53 · Revenue $23.55M
EPS $-0.94 · Revenue $17.68M
EPS $-0.80 · Revenue $17.31M
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $92.4M | +201.7% | +29.3% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $-37.7M | +18.6% | +61.1% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +52.8% | +5.0% | +0.3% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | -41.3% | +73.8% | -74.7% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | -40.8% | +73.0% | +69.9% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $-22.0M | +26.5% | +100.0% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | -23.8% | +75.6% | +100.0% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 1.3% | -62.7% | +94.3% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 3.01x | +27.9% | -21.6% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $203.5M | -4.7% | -12.3% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | -2.68 vs -2.52 | -6.5% | -0.52 vs -0.77 | +32.8% |
| Revenue Surprise | $92.4M vs $90.1M | +2.5% | $46.5M vs $63.1M | -26.3% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | Rosin Brian J | officer: CFO of IM8 (US) LLC | Class A Ordinary Share, par value $0.0015 per share | A | 5,100 | $22.80 |
| Aug 24, 2026 | Rosin Brian J | officer: CFO of IM8 (US) LLC | Class A Ordinary Share, par value $0.0015 per share | A | 18,000 | $21.19 |
| Aug 24, 2026 | Yeung Danny Sheng Wu | director, officer: Chief Executive Officer | Class A Ordinary Share, par value $0.0015 per share | A | 11,181 | $21.40 |
| Aug 24, 2026 | Yeung Danny Sheng Wu | director, officer: Chief Executive Officer | Class A Ordinary Share, par value $0.0015 per share | A | 6,000 | $20.90 |
| Aug 21, 2026 | Lo Hoi Chun | officer: Chief Financial Officer | Class A Ordinary Share, par value $0.0015 per share | A | 45,815 | — |
Operator: Actual results may differ materially. Please refer to the company's filings with the SEC. Certain figures for July are preliminary and unaudited. The full Q2 2026 shareholder letter and this investor presentation were published this morning and are available at ir.prenetics.com. With that, it is my pleasure to hand the call over to Prenetics CEO, Danny. Sheng Wu Yeung: Thank you, Shannon. Good morning, everyone. Before anything else, thank you so much for being here. This is actually the first live earnings video webcast we've done in our company's history. And from the numbers looking -- from numbers that are joining right now, it may be the largest group of our shareholders ever gathered in one place. So whether you manage a fund, hold a single share or simply here because you drink the sachet every morning, welcome. This is for you. And here's why we're doing it this way. Our shareholders range from global institutions to people who found IM8 as customers and became shareholders. And we believe every one of them deserves the same depth of information at the same moment. This moment, we've opened the books to everyone at once. We can do that for a simple reason. We now have 20 months of data, every cohort, every month, every market measured end-to-end. Enough history that numbers no longer need my adjectives. And I will say this plainly, I do not know of another company publicly traded or private that has shown its business in this level of detail in which we are showing you today. I just released a 40-page shareholder letter written to be read, not skimmed, an additional 80-page investor deck that shows you this business the way I see it internally, every single cohort, every vintage, our full acquisition cost month by month and even independent card data measuring our retention against every single brand in our category. In this stream, you hear from us directly and feel free to ask us anything at the end of this call. And the business compounding this fast deserves to be examined, not summarized. When the numbers are this good, transparency is a weapon. And today, and day that number softens, someday you'll read it from us first in that letter. And one promise I want to make in the next half hour is not -- I'm not going to be standing here and just reading you that letter. However, hopefully, everyone here listening in can read it later today. What I owe you is a part of the document that cannot do the story of what actually happened, how a brand that did not exist two Decembers ago crossed last month, the most -- crossed last month a line most consumer companies never reach. But before I talk about single number, I want to see what -- I want to show everyone what we're building first. We made this video 2 minutes. Please enjoy. [Presentation] Sheng Wu Yeung: Yes. I mean that was a highlight for the last 20 months, and it's quite amazing what we've been able to achieve, right? So Brian, if we get to the next slide. In December …
| Name | Title | Gender | Year Born | Status |
|---|---|---|---|---|
James DiNicolantonio | Chief Nutrition Officer, Member of Scientific & Medical Advisory Board | — | — | Active |
Senthil Sundaram | Chief Clinical Officer | — | 1974 | Active |
Sheng Wu Yeung | Co-Founder, Chairperson & Chief Executive Officer | Male | 1979 | Active |
Brian J. Rosin | Chief Financial Officer of U.S. | Male | — | Active |
David Eric Vanderveen | President of Americas | Male | 1969 | Active |
Samantha Kwok | Chief of Staff & VP of People & Operations | Female | — | Active |
Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation
Alphabet shares pare back overnight as investors scrutinise its ever-increasing capex plans. Tesla is also down after missing on earnings while free cash flow turns negative.
IM8 is the fastest-growing premium supplement brand ever recorded — over 50 million servings delivered to date, with approximately 200,000 servings currently delivered daily, and an order every 27 seconds Prenetics raises full-year 2026 IM8 revenue guidance to $210–220 million, up from $190–210 million IM8 expected to reach $300 million in annualized run-rate revenue by year-end 2026 IM8 expected to deliver $400 million or more in full-year 2027 revenue Every $1 invested in customer acquisition has returned $1.44 in gross profit, blended across all mature cohorts NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health company and parent of the AI-native direct-to-consumer wellness brand IM8, co-founded by David Beckham, today announced the closing of $1 billion in growth financing from General Catalyst's Customer Value Fund (“CVF”). Under the arrangement, General Catalyst's Customer Value Fund will finance up to 70% of IM8's marketing spend, with IM8 retaining full discretion over facility utilization.
IRVINE, Calif., July 9, 2026 /PRNewswire/ -- VinFast (Nasdaq: VFS) today announced the official launch of its Certified Pre-Owned (CPO) Program in the United States.
Unlock more of Europe with immersive destination discovery and personalized experiences, all with Celebrity Cruises' signature hospitality, in Prague, Budapest, Amsterdam and Lausanne. MIAMI, June 30, 2026 /PRNewswire/ -- Starting today, Celebrity River Cruises guests can discover even more of Europe with guided, multi-day Before and After Stays — thoughtfully curated, end-to-end destination experiences.
